Breast cancer subtypes: response to radiotherapy and potential radiosensitisation
Identifieur interne : 003842 ( Main/Exploration ); précédent : 003841; suivant : 003843Breast cancer subtypes: response to radiotherapy and potential radiosensitisation
Auteurs : F E Langlands [Royaume-Uni] ; K. Horgan [Royaume-Uni] ; D D Dodwell [Royaume-Uni] ; L. Smith [Royaume-Uni]Source :
- The British Journal of Radiology [ 0007-1285 ] ; 2013.
Abstract
Radiotherapy (RT) is of critical importance in the locoregional management of early breast cancer. Over 50% of patients receive RT at some time during the treatment of their disease, equating to over 500 000 patients worldwide receiving RT each year. Unfortunately, not all patients derive therapeutic benefit and some breast cancers are resistant to treatment, as evidenced by distant metastatic spread and local recurrence. Prediction of individual responses to RT may allow a stratified approach to this treatment permitting those patients with radioresistant tumours to receive higher doses of RT (total and/or tumour cavity boost doses) and/or radiosensitising agents to optimise treatment. Also, for those patients unlikely to respond at all, it would prevent harmful side effects occurring for no therapeutic gain. More selective targeting would better direct National Health Service resources, ease the burden on heavily used treatment RT machines and reduce the economic cost of cancer treatment. Unfortunately, there are no robust and validated biomarkers for predicting RT outcome. We review the available literature to determine whether classification of breast cancers according to their molecular profile may be used to predict successful response to, or increased morbidity from, RT. Class-specific biomarkers for targeting by radiosensitising agents are also discussed.
Url:
DOI: 10.1259/bjr.20120601
PubMed: 23392193
PubMed Central: 3608055
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 004774
- to stream Pmc, to step Curation: 004773
- to stream Pmc, to step Checkpoint: 002471
- to stream Ncbi, to step Merge: 005604
- to stream Ncbi, to step Curation: 005604
- to stream Ncbi, to step Checkpoint: 005604
- to stream Main, to step Merge: 003850
- to stream Main, to step Curation: 003842
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Breast cancer subtypes: response to radiotherapy and potential radiosensitisation</title>
<author><name sortKey="Langlands, F E" sort="Langlands, F E" uniqKey="Langlands F" first="F E" last="Langlands">F E Langlands</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><addr-line>Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds, UK</addr-line>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Horgan, K" sort="Horgan, K" uniqKey="Horgan K" first="K" last="Horgan">K. Horgan</name>
<affiliation wicri:level="1"><nlm:aff id="aff2"><addr-line>Department of Breast Surgery, Leeds General Infirmary, Leeds, UK</addr-line>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Breast Surgery, Leeds General Infirmary, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dodwell, D D" sort="Dodwell, D D" uniqKey="Dodwell D" first="D D" last="Dodwell">D D Dodwell</name>
<affiliation wicri:level="1"><nlm:aff id="aff3"><addr-line>St James’s Institute of Oncology, St James Hospital, Leeds, UK</addr-line>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>St James’s Institute of Oncology, St James Hospital, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Smith, L" sort="Smith, L" uniqKey="Smith L" first="L" last="Smith">L. Smith</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><addr-line>Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds, UK</addr-line>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23392193</idno>
<idno type="pmc">3608055</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608055</idno>
<idno type="RBID">PMC:3608055</idno>
<idno type="doi">10.1259/bjr.20120601</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">004774</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004774</idno>
<idno type="wicri:Area/Pmc/Curation">004773</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">004773</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002471</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002471</idno>
<idno type="wicri:Area/Ncbi/Merge">005604</idno>
<idno type="wicri:Area/Ncbi/Curation">005604</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005604</idno>
<idno type="wicri:doubleKey">0007-1285:2013:Langlands F:breast:cancer:subtypes</idno>
<idno type="wicri:Area/Main/Merge">003850</idno>
<idno type="wicri:Area/Main/Curation">003842</idno>
<idno type="wicri:Area/Main/Exploration">003842</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Breast cancer subtypes: response to radiotherapy and potential radiosensitisation</title>
<author><name sortKey="Langlands, F E" sort="Langlands, F E" uniqKey="Langlands F" first="F E" last="Langlands">F E Langlands</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><addr-line>Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds, UK</addr-line>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Horgan, K" sort="Horgan, K" uniqKey="Horgan K" first="K" last="Horgan">K. Horgan</name>
<affiliation wicri:level="1"><nlm:aff id="aff2"><addr-line>Department of Breast Surgery, Leeds General Infirmary, Leeds, UK</addr-line>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Breast Surgery, Leeds General Infirmary, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dodwell, D D" sort="Dodwell, D D" uniqKey="Dodwell D" first="D D" last="Dodwell">D D Dodwell</name>
<affiliation wicri:level="1"><nlm:aff id="aff3"><addr-line>St James’s Institute of Oncology, St James Hospital, Leeds, UK</addr-line>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>St James’s Institute of Oncology, St James Hospital, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Smith, L" sort="Smith, L" uniqKey="Smith L" first="L" last="Smith">L. Smith</name>
<affiliation wicri:level="1"><nlm:aff id="aff1"><addr-line>Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds, UK</addr-line>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, Leeds University, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">The British Journal of Radiology</title>
<idno type="ISSN">0007-1285</idno>
<idno type="eISSN">1748-880X</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Radiotherapy (RT) is of critical importance in the locoregional management of early breast cancer. Over 50% of patients receive RT at some time during the treatment of their disease, equating to over 500 000 patients worldwide receiving RT each year. Unfortunately, not all patients derive therapeutic benefit and some breast cancers are resistant to treatment, as evidenced by distant metastatic spread and local recurrence. Prediction of individual responses to RT may allow a stratified approach to this treatment permitting those patients with radioresistant tumours to receive higher doses of RT (total and/or tumour cavity boost doses) and/or radiosensitising agents to optimise treatment. Also, for those patients unlikely to respond at all, it would prevent harmful side effects occurring for no therapeutic gain. More selective targeting would better direct National Health Service resources, ease the burden on heavily used treatment RT machines and reduce the economic cost of cancer treatment. Unfortunately, there are no robust and validated biomarkers for predicting RT outcome. We review the available literature to determine whether classification of breast cancers according to their molecular profile may be used to predict successful response to, or increased morbidity from, RT. Class-specific biomarkers for targeting by radiosensitising agents are also discussed.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Langlands, F E" sort="Langlands, F E" uniqKey="Langlands F" first="F E" last="Langlands">F E Langlands</name>
</noRegion>
<name sortKey="Dodwell, D D" sort="Dodwell, D D" uniqKey="Dodwell D" first="D D" last="Dodwell">D D Dodwell</name>
<name sortKey="Horgan, K" sort="Horgan, K" uniqKey="Horgan K" first="K" last="Horgan">K. Horgan</name>
<name sortKey="Smith, L" sort="Smith, L" uniqKey="Smith L" first="L" last="Smith">L. Smith</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003842 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003842 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:3608055 |texte= Breast cancer subtypes: response to radiotherapy and potential radiosensitisation }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23392193" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |